Yet for many people with hormonal or metabolic drivers of obesity, calorie restriction and activity alone produce slow or limited weight loss
Baseline metabolic status matters too, since higher insulin resistance may bring earlier glucose-related benefits while a lower starting weight often means more gradual change
Its entry follows the launch of Wegovy, another semaglutide-based drug, in June 2025, intensifying competition in the GLP-1 receptor agonist segment
Frequently Asked Questions Is Ozempic approved for treating binge eating disorder in the UK
Candidates must be screened for thyroid cancer risk, pancreatitis history, gallbladder and kidney disease, and mental health history before starting
This results in better physical output during training or competition